(NASDAQ: CLNN) Clene's forecast annual revenue growth rate of 555.05% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.13%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Clene's revenue in 2025 is $421,000.On average, 2 Wall Street analysts forecast CLNN's revenue for 2025 to be $3,989,863, with the lowest CLNN revenue forecast at $3,191,890, and the highest CLNN revenue forecast at $4,787,836. On average, 2 Wall Street analysts forecast CLNN's revenue for 2026 to be $51,868,219, with the lowest CLNN revenue forecast at $3,191,890, and the highest CLNN revenue forecast at $100,544,548.
In 2027, CLNN is forecast to generate $1,113,171,777 in revenue, with the lowest revenue forecast at $653,539,559 and the highest revenue forecast at $1,572,803,995.